Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
The FDA approved Abbott Laboratories ABT spinal cord stimulation (SCS) devices for chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back ...
Chronic pain affects millions of individuals, considerably impacting their quality of life and emotional well-being. You may find that it alters your daily activities, leading to frustration and ...
DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop ...
Please provide your email address to receive an email when new articles are posted on . Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic ...
Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts ...
The closed-loop feature of the Inceptiv SCS senses neural responses and is able to automatically adjust stimulation in real time. The Food and Drug Administration (FDA) has approved the Inceptiv ™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results